Psychiatric Annals

Feature Article 

Biofeedback and Neurofeedback Treatment for ADHD

Nicholas Lofthouse, PhD; Keith McBurnett, PhD; L. Eugene Arnold, MD, MEd; Elizabeth Hurt, PhD

Abstract

Although many children, adolescents, and adults with attention deficit/hyperactivity disorder benefit significantly from evidence-based treatments, such as medication, behavioral therapy, and cognitive behavioral therapy, for some patients, these treatments are not helpful. Others refuse to try them, even though they may be beneficial.


ABOUT THE AUTHORS

Nicholas Lofthouse, PhD, is with the Department of Psychiatry, The Ohio State University, Columbus, Ohio. Keith McBurnett, PhD, is with the Department of Psychiatry, University of California, San Francisco. L. Eugene Arnold, MD, MEd, is with the Department of Psychiatry; and the Nisonger Center, The Ohio State University. Elizabeth Hurt, PhD, is with the Nisonger Center, The Ohio State University.

Address correspondence to: Nicholas Lofthouse, PhD, Department of Psychiatry, The Ohio State University, 1670 Upham Drive, Room 560-A, Columbus, OH 43210-1250; fax: 614-293-8232; or e-mail: Nicholas.Lofthouse@osumc.edu.

Dr. Lofthouse; and Dr. Hurt have disclosed no relevant financial relationships. Dr. Arnold has disclosed the following relevant financial relationships: Noven: Consultant; and CureMark; Eli Lilly; and Shire: Contracted Research. Dr. McBurnett has disclosed the following relevant financial relationships: Eli Lilly and Shire; Consultant; and Eli Lilly, Otsuka, and Shire: Contracted research.

Abstract

Although many children, adolescents, and adults with attention deficit/hyperactivity disorder benefit significantly from evidence-based treatments, such as medication, behavioral therapy, and cognitive behavioral therapy, for some patients, these treatments are not helpful. Others refuse to try them, even though they may be beneficial.


ABOUT THE AUTHORS

Nicholas Lofthouse, PhD, is with the Department of Psychiatry, The Ohio State University, Columbus, Ohio. Keith McBurnett, PhD, is with the Department of Psychiatry, University of California, San Francisco. L. Eugene Arnold, MD, MEd, is with the Department of Psychiatry; and the Nisonger Center, The Ohio State University. Elizabeth Hurt, PhD, is with the Nisonger Center, The Ohio State University.

Address correspondence to: Nicholas Lofthouse, PhD, Department of Psychiatry, The Ohio State University, 1670 Upham Drive, Room 560-A, Columbus, OH 43210-1250; fax: 614-293-8232; or e-mail: Nicholas.Lofthouse@osumc.edu.

Dr. Lofthouse; and Dr. Hurt have disclosed no relevant financial relationships. Dr. Arnold has disclosed the following relevant financial relationships: Noven: Consultant; and CureMark; Eli Lilly; and Shire: Contracted Research. Dr. McBurnett has disclosed the following relevant financial relationships: Eli Lilly and Shire; Consultant; and Eli Lilly, Otsuka, and Shire: Contracted research.

10.3928/00485713-20101221-07

Sign up to receive

Journal E-contents